Physician profile
Garrett Ka Keung Lam
NPI 1033172713
$15,511.86
in general payments reported to CMS, 2019-2025
5 companies · $4,294 in 2025
The $4,294 reported for 2025 was more than what 94% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.22 · 2021: $62.72 · 2022: $1,359 · 2023: $4,775 · 2024: $5,002 · 2025: $4,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,381 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,545 · Travel and Lodging: $2,270 · Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,381.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,545.19 |
| Travel and Lodging | $2,269.64 |
| Food and Beverage | $876.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $15,186.80 | 2021-2025 | Kiwi Procup |
| Biogen, INC. | $156.18 | 2023-2025 | Zurzuvae |
| Alexion Pharmaceuticals, INC. | $108.59 | 2022 | |
| Fisher Scientific Company L.L.C. | $42.07 | 2024 | Procalcitonin |
| Clinical Innovations, LLC | $18.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.